- Home
- ODC vs RCUS Comparison
ODC vs RCUS Comparison
Compare ODC & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ODC
- RCUS
- Stock Information
- Founded
- ODC 1941
- RCUS 2015
- Country
- ODC United States
- RCUS United States
- Employees
- ODC N/A
- RCUS N/A
- Industry
- ODC Miscellaneous manufacturing industries
- RCUS Biotechnology: Pharmaceutical Preparations
- Sector
- ODC Consumer Discretionary
- RCUS Health Care
- Exchange
- ODC Nasdaq
- RCUS Nasdaq
- Market Cap
- ODC 853.6M
- RCUS 906.4M
- IPO Year
- ODC N/A
- RCUS 2018
- Fundamental
- Price
- ODC $60.33
- RCUS $8.47
- Analyst Decision
- ODC
- RCUS Buy
- Analyst Count
- ODC 0
- RCUS 10
- Target Price
- ODC N/A
- RCUS $23.75
- AVG Volume (30 Days)
- ODC 81.7K
- RCUS 1.1M
- Earning Date
- ODC 06-05-2025
- RCUS 08-07-2025
- Dividend Yield
- ODC 1.19%
- RCUS N/A
- EPS Growth
- ODC 17.38
- RCUS N/A
- EPS
- ODC 3.40
- RCUS N/A
- Revenue
- ODC $474,062,000.00
- RCUS $141,000,000.00
- Revenue This Year
- ODC N/A
- RCUS N/A
- Revenue Next Year
- ODC N/A
- RCUS $28.73
- P/E Ratio
- ODC $17.76
- RCUS N/A
- Revenue Growth
- ODC 9.92
- RCUS N/A
- 52 Week Low
- ODC $29.47
- RCUS $6.50
- 52 Week High
- ODC $60.70
- RCUS $18.98
- Technical
- Relative Strength Index (RSI)
- ODC 68.88
- RCUS 45.47
- Support Level
- ODC $56.28
- RCUS $7.92
- Resistance Level
- ODC $60.70
- RCUS $8.81
- Average True Range (ATR)
- ODC 1.89
- RCUS 0.45
- MACD
- ODC -0.08
- RCUS -0.06
- Stochastic Oscillator
- ODC 93.07
- RCUS 39.02
About ODC Oil-Dri Corporation Of America
Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups namely Retail and Wholesale Products Group and Business to Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.